ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.

@article{Geskin2007ECPVP,
  title={ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.},
  author={Larisa J. Geskin},
  journal={Skin therapy letter},
  year={2007},
  volume={12 5},
  pages={1-4}
}
Extracorporeal photopheresis (ECP) and psoralen plus ultraviolet A therapy (PUVA) are widely accepted types of photochemotherapy used for the treatment of cutaneous T-cell lymphomas (CTCL). PUVA and ECP utilize a photosensitizing agent, that can be taken orally (PUVA) or added to the concentrated sample of white blood cells extracorporeally (ECP) prior to UVA exposure. Both therapies have been shown to be safe and effective for the treatment of CTCL. As a monotherapy, PUVA is preferentially… CONTINUE READING